Additional information
White Powder
51333-05-2
ACI-020511
155.8-156.7°C
C27H36O7
472.57
Ambient
2-8°C
Corticosteroids
Pharmaceutical Impurity Standards
16a,17-[(1RS)-butylidenebis(oxy)]-11ß,21-dihydroxypregna-1,4-diene-3,20-dione-21-acetate
16a,17-[(1RS)-butylidenebis(oxy)]-11ß,21-dihydroxypregna-1,4-diene-3,20-dione-21-acetate
Budesonide 21-Acetate (USP;16?,17-[Butylidenebis(oxy)]-11?-hydroxypregna-1,4-diene-3,20-dione-21-yl acetate (as per USP)





![TOFACITINIB DIMER (25 mg) (1,3-Bis{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-1,3-propanedione)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)